Clinical Trials

23 enrolled

Gastrointestinal Stromal Tumors

NCT04546074 2023-10-03

Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma

Phase 1/2 Unknown

22 enrolled

Dermatologic

Melanoma

NCT02365441 2023-07-07

ALT GIST

78 enrolled

Gastrointestinal Stromal Tumors

NCT05895942 2023-06-09

EMMBKM

Unknown

190 enrolled

Sarcoma

GIST

NCT04138381 2023-03-27

SeliGIST

Phase 1/2 Unknown

Sarcoma

Neoplasm Metastasis, Sarcoma, Drug-Related Side Effects and Adverse Reactions

NCT02461849 2022-06-15

Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy

14 enrolled

Tumor-Agnostic

Neoplasms

NCT02602314 2022-01-20

SUSTRENIM

Phase 4 Unknown

450 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04578847 2020-10-08

READIT

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

90 enrolled

Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT03862768 2019-03-05

Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment

Phase NA Unknown

92 enrolled

Gastrointestinal Stromal Tumors

NCT03381053 2017-12-21

Study to Compare Pathologic Type, NIH and WHO Criteria,and Mechanism of GIST Malignant Transformation

Unknown

3,000 enrolled

Tumor-Agnostic

Neoplasms

NCT03331211 2017-11-08

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

Unknown

Phase EARLY_PHASE1 Unknown

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03228303 2017-10-10

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03241199 2017-08-08

The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia

15 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02894645 2016-09-30

Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study

Phase 4 Unknown

500 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02013089 2016-08-30

GITIC

Phase NA Unknown

50 enrolled

Gastrointestinal

Gastrointestinal Neoplasms

NCT02687425 2016-02-22

SESPI

20 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02576080 2015-10-15

GIGIST

80 enrolled

Gastrointestinal Stromal Tumors

NCT02317159 2014-12-15

Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia

Phase 4 Unknown

90 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00685828 2014-07-04

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

946 enrolled

Gastrointestinal Stromal Tumors

NCT01400074 2014-01-13

RE-NICE

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01005758 2014-01-10

Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

180 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00028847 2013-09-17

Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia

Phase 1/2 Unknown

60 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00904735 2013-08-12

Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma

76 enrolled

CNS

Brain Neoplasms, Meningioma, Central Nervous System Neoplasms

NCT01503502 2013-04-10

A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

150 enrolled

Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01221376 2013-03-26

Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)

20 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01782508 2013-02-04

A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma

40 enrolled

Dermatologic

Melanoma

NCT01175109 2012-12-27

Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma

Phase 1 Unknown

36 enrolled

Sarcoma

Chordoma

NCT01227135 2011-11-30

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

66 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00112775 2011-06-07

BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00551252 2007-10-30

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Other solid neoplasmThoracic

56 enrolled

Mesothelioma

NCT00199186 2007-10-19

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00297570 2007-10-10

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

90 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00180921 2007-09-26

Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

Head & Neck

Carcinoma, Adenoid Cystic, Head and Neck Neoplasms

NCT00146913 2007-04-27

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00149136 2007-04-27

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00327262 2006-06-20

Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

240 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00290485 2006-04-07

Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)

50 enrolled